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MUCH work has been published on theeffect onliver catalase oftumour growth,
and of the injection of whole or semi-purified tumour homogenates, but in all
these studies the sole criterion of activity has been a simple depression in catalase
level. An increasingly large number of substances apparently unrelated to
tumour tissue, have been shown to depress liver catalase activity on injection,
e.g. methyl bis (B-chlorethyl) amine, 9: 10-dimethyl-1: 2-benzanthracene, butter
yellow and its 3'methyl demative, 4'-amino-2: 3-dimethylaminoazobenzene, B-
naphthylamine, benzpyrene (Adams and Roe, 1953), homogenised normal spleen
tissue (Day, Gabrielson and Lipkind, 1954), aminotriazole (Heim, Appleman and
Pyrform, 1955) allyl isopropyl acetyl carbamide (Schmidt, Figen and Schwarz,
1955), cysteine and a number ofits derivatives (Hirai and Deutsch, 1958), thiourea
(Margoliash, 1958, personal communication), testosterone and 17-methyl testo-
sterone (Adams, 1960).
There is little direct evidence about the mechanism by which these substances
depress catalase activity in vivo. Probably none of them directly inhibit the
enzyme. Amino triazole acts in vitro by combining with catalase-hydrogen
peroxide Complex I (Margoliash andNorogrodsky, 1958). However this substance
is characterised in vivo by an extremely rapid action-liver catalase activity being
reduced almost to zero in a few hours. It is well known that hydrogen peroxide
destroys catalase and therefore one possible explanation is that these substances
affect catalase activity through the production of hydrogen peroxide during their
metabolism. Certainly if every substance which gives rise to H202 in vivo de-
presses catalase activity, such depressions are completely non-specific. Has then
tumour growth or tumour tissue any specific action on liver catalase ?
Adams and Burgess (1959a) recently showed that when liver slices were
incubated in vitro in a phosphate saline medium, catalase migrated from the
large granules into the extra particulate cytoplasm (EPC). This observation led
to the suggestion (Adams, 1960) that such catalase migration may occur in vivo
and that catalase is synthesised only in the large granules. On this view the
EPC level would be maintained by catalase derived from the granules by migration
through the granule membranes. If this is correct, then the permeability of the
granule membranes will be one ofthe factors determining the EPC catalase level.
Adams (1960) also suggested that, in the simplest analysis, the granule/EPC
catalase distribution ratio would provide an approximate index of granule perme-
ability. He showed that after the injection of cysteine, methyl butter yellow, or
thiourea, depressions in catalase activity were observed in both granule and EPCEFFECT OF SARCOMA 37 ON MOUSE LIVER CATALASE
fractions, but that these changes occurred without alteration in the granule/EPC
distribution ratio. Further evidence in the same paper showed that androgenic
hormones altered the granule/EPC distribution ratio in a way consistent with
the supposition that they act by increasing the permeability of the large-granule
membranes to catalase. Adams (1951) found that there appeared to be an antag-
onism between the action of testicular and adrenal hormones, and that of tumour
homogenate or catalase activity.
The purpose of this paper is to make a preliminary study of the action of
tumour growth and tumour homogenate on intracellular catalase distribution.
MATERIALS AND METHODS
Animals. Young adult mice of the 101 and CBA strains and of an albino
strain derived from AKR were used. These animals were all bred in this laboratory
by brother-sister mating, but some AKR-substrain mice were obtaiiied direct
from the Laboratory Animal Bureau.
Preparation of liver fractions and estimation of liver catalase activity.-Catalase
estimations were made on whole liver homogenates, and on granule and EPC
fractions. The method of estimation of catalase activity has been fully described
in previous publications (Adams, 1950, 1952) and the preparation of the homo-
genates and fractions by Adams and Burgess (1957, 1959a). Ethanol (final con-
centration 0.01 M.) was added to all catalase containing solutions to prevent loss
of catalase due to" Complex II" formation (Chance, 1950; Adams and Burgess,
1959b).
Tumour.- Sarcoma 37 was obtained originally from the Imperial Cancer
Research Fund Laboratories and maintained by serial passage in this laboratory.
Triton x 100.-This non-ionic detergent (kindly given to us by Charles Lennig
& Co.) was used at a final concentration of 0.25 per cent v/v to disrupt large
granules and liberate their catalase activity into solution.
RESULTS
The injection of normal tissue
Adams (1950), working with homogenates containing principally EPC fraction,
found that the injection of 50 mg. doses of normal tissue did not depress catalase
activity significantly. In view of the finding by Day et al. (1954) that injections
of homogenised spleen did depress liver catalase activity, the effect of larger
doses of normal tissue on total, granule, and EPC catalase was investigated. The
normal tissue used was a mixture of the liver, spleen, and kidneys taken from
sufficient CBA mice to provide the total required. The mixed tissues were homo-
genised (50 strokes with a Ten Broeck grinder) and injected subcutaneously in
100 and 200 mg. doses into AKR-substrain female mice. As shown in Fig. 1 the
lower dose produced only a slight depression in catalase activity, but the higher
dose resulted in considerable depression in catalase activity in both granule and
EPC fractions. However, the granule/EPC catalase distribution ratio remained
almost unaltered through the course of the experiment. Fig. 1 also shows that
the effect of a single injection of homogenised rat liver (100 mg.) was similar to
that produced by the same dose of mouse tissue. Closely similar results, i.e.
depression in catalase activity with little or no alteration in the distribution ratio,
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were obtained after the injection of cysteine, thiourea, and butter yellow (Adams,
1960).
The injection of tumour tissue
Fig. 2 shows the result ofthe injection of 100 mg. and 200 mg. of homogenate
prepared in a similar way from Sarcoma 37 into AKR-substrain females. As with
normal tissue, depressions in catalase activity were observed, but with the
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FIG. 1.-The effect of the injection of homogenised normal tissue on the catalase activity and
granule/EPC catalase distribution ratio of AKR-substrain $ mice. (a) and (b) 100 mg.
and 200 mg. of mixed liver kidney and spleen from CBA mice. (c) 100 mg. of similar tissue
from albino rats. Injection at 0 days.
A A Total catalase. O Granule catalase.
* * EPC catalase.
Results are expressed in this and subsequent figures as arithmetic means + Std. errors of
means. Twelve control and eight treated animals/group.
Ordinate.-Catalase activity in arbitrary units/mg. N.
Abscissae.-Time in days.
difference that the granule/EPC catalase distribution ratio increased considerably.
Fig. 3 shows the results of the injection of 100 mg. of normal tissue, and 100 mg.
of tumour tissue, into CBA males. The normal tissue resulted in depression in
catalase activity without alteration in the granule/EPC distribution ratio (3-3 in
normal males). The injection of tumour homogenate resulted in an increase in
the ratio to 4.6.
Tumour growth
The effect of tumour growth on the catalase activity and granule/EPC dis-
tribution ratio in AKR-substrain female and 101 male and female mice is shown
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FIG. 2.-The effect of the injection of homogenised S37 tissue on the catalase activity and
granule/EPC catalase distribution ratio of AKR-substrain ? mice. (a) 100 mg. (b) 200 mg.
injected at 0 days.
A A Total catalase. O O Granule catalase.
* * EPC catalase.
Ordinate.-Catalase activity in arbitrary unlmits/mg. N.
Abscissae.-Time in days.
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FIG. 3.-The effect of the injection ofhomogenised tissue on the catalase activity and granule/
EPC catalase distribution ratio of CBA ' mice.
(a) 100 mg. liver-kidney-spleen taken from AKR mice.
(b) 100 mg. S37 tissue.
A A Total catalase. O O Granule catalase.
0 * EPC catalase.
Ordinwte.-Catalase activity in arbitrary units/mg. N.
Ab8zissae.-Time in days.
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in Fig. 4. Progressive decreases in catalase activity in both granules and EPC
were associated with progressive increases in the granule/EPC distribution ratio.
In the AKR-substrain mice considerable tumour necrosis was found, but little
or none in the 101 mice.
DISCUSSION
Surprisingly enough perhaps comparatively little work has been done on
direct comparison of the effect of the injection of normal and tumour tissue on
liver catalase. Adams (1950) (measuring principally EPC catalase) found that
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FIG. 4.-Effect of S37 tumour growth on catalase activity and granule/EPC catalase distri-
bution ratio of (a) AKR-substrain 9 mice. (b) 101 Y mice. (c) 101 d mice. The tumour
bearing mice were formed into groups of 6-8 animals bearing tumours ofsimilar size and the
tumour weights averaged to give the points on the graphs.
A A Total catalase. O O Granule catalase.
* 0 EPC catalase.
Ordinate.-Catalase activity in arbitrary units/mg. N.
Abscissae.-Tumour weight in grams.
the injection of 50 mg. dose of normal tissue did not depress mouse liver catalase
significantly, but 50 mg. dose of S37 did. The present work shows clearly that
catalase depressions may easily be obtained after the injection of normal tissue,
provided that the dose is sufficiently high. This depression of catalase activity by
normal tissue injection confirms the result of Day et al. (1954). In fact if only
total catalase activity is considered normal tissue homogenate may depress catalase
to the same extent, dose for dose, as tumour homogenate. The effect on the
intracellular (granule/EPC) catalase distribution ratio was however quite
different. Normal tissue homogenate did not alter this ratio in either sex, and
this resembled thiourea, cysteine and methyl butter yellow in this respect (Adams,
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1960). On the other hand, tumour homogenate increased the granule/EPC ratio
considerably in both sexes, and the same phenomenon was seen during tumour
growth. The results suggest that injected tumour tissue has two separate actions
on catalase. Firstly, the total enzyme level is decreased, an effect which also
occurs with normal tissue, and secondly, superimposed on this, there is an increase
in thegranule/EPC distribution ratio. This action on the distribution ratio, which
is apparently specific, shows itself principally by a decrease in the EPC level.
Thus if a comparison is made of the action of tumour homogenate and normal
tissue homogenate on the EPC catalase level only, tumour tissue will produce a
greater depression compared with normal tissue. This accounts for the results
previously reported (Adams, 1950) that 50 mg. tumour homogenate significantly
depressed the (EPC) catalase activity whereas no depression was caused by normal
tissue homogenate.
The results given here, taken in conjunction with those summarised in the
introduction, make it clear that a simple catalase depression is not in the least a
specific action of tumour tissue or of tumour growth.
It seems also quite clear that the fractions derived from tumour tissue by
various investigators cannot, on the available evidence, be said to contain any
specific tumour agent. These fractions have been tested solely on the basis of
their ability to depress catalase activity in vivo afterinjection. There are obviously
many substances which could be present in varying amounts in tumour tissue
and in normal tissue, which will produce a catalase depression when injected in
adequate dosage.
Tumour growth resulted in a progressive fall in catalase activity, and a pro-
gressive increase in granule/EPC distribution ratio. However the catalase acti-
vities in these mice fell to lower levels than those observed after injections oftissue
homogenates. This point will be dealt with in a future publication.
Adams (1960) showed that androgenic hormones injected into female mice
exerted a specific effect in decreasing the liver catalase granule/EPC distribution
ratio from the normal value of about 5.0, to the normal male value of about
3-3. This was interpreted as showing that the hormones increase the permeability
of the granule membranes to catalase. On the same view, the increase in distri-
bution ratio caused by tumour growth and tumour tissue would result from a
decrease in the permeability of the large-granule membranes to catalase. The
antagonistic action of tumour tissue and hormones reported by Adams (1951)
appears therefore to result from their opposite effects on granule membrane
permeability.
SUMMARY
(1) Depression of liver catalase activity results equally well from injections of
S37 homogenate or normal tissue homogenates.
(2) S37 homogenate increases the granule/EPC catalase distribution ratio,
but normal tissue does not.
(3) It is concluded that S37 homogenate contains an agent which decreases
the permeability of the granule membranes to catalase.
REFERENCES
ADAMS, D. H.-(1950) Brit. J. Cancer, 4, 183.-(1951) Ibid., 5, 115.-(1952) Biochem. J.,
50, 486.-(1960) Ibid. 74, 141.710 D. H. ADAMS
Idem AND BURGESS, E. A.-(1957) Brit. J. Cancer, lt, 310.-(1959a) Biochem. J. 71,
340.-(1959b) Enzymologia 20, 341.
Idem AND ROE, F. J. C.-(1953) Brit. J. Cancer, 7, 509.
CHANCE, B.-(1950) Biochem. J., 46, 387.
DAY, E. D., GABRIELSON, F. C. AND LIPKIND, J. P.-(1954) J. nazt. Cancer Inst., 15,
239.
HEIM, W. G., APPLEMAN, D. AND PYRFORM, H. T.-(1955) Science, 122, 693.
HIRAI, H. AND DEUTSCH, H. F.-(1958) Cancer Res., 18, 283.
MARGOLIASH, E. AND NOVOGRODSKY, A.-(1958) Biochem. J., 68, 468.
SCHMIDT, R. FIGEN, J. F. AND SCHWARZ, S.-(1955) J. Biol. Chem., 217, 263.